Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company.
Cambridge biotech Alchemab Therapeutics has extended its Series A round with a £25 million ($34 million) investment from the British Business Bank, which the company says is the state-owned lender’s largest backing of a life sciences company to date…. [3793 chars]
Source: TNW | Published: 2026-07-09T08:15:30Z
Credit: TNW
